Last Updated:
3:03 pm
Wednesday, June 25, 2025
Noxopharm Ltd. engages in the research and development of drugs. It focuses on sensitizing cancer cells to radiotherapy and chemotherapy. The company was founded by Graham Kelly on October 27, 2015 and is headquartered in Chatswood, Australia.
asx-nox
Market Cap
AU$19.00M
Volume
91700
Open
0.05
AU$
High
0.05
AU$
Low
0.05
AU$
Shares On Issue
292M
52 Week Low
0.05
AU$
52 Week High
0.15
AU$
Website
www.noxopharm.com
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved